These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38357982)

  • 1. Trichorhinophalangeal Syndrome Type 1 Immunohistochemical Expression in Carcinomas of Gynecologic Origin.
    Ruiz F; Tjendra Y; Millan N; Gomez-Fernandez C; Pinto A
    Am J Surg Pathol; 2024 May; 48(5):546-550. PubMed ID: 38357982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
    Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenocarcinomas of the Gynecologic Tract Involving the Urinary Bladder: A Series of 16 Cases Potentially Mimicking Urothelial Malignancy.
    Russell DH; Epstein JI; Kryvenko ON; Schlumbrecht M; Jorda M; Pinto A
    Arch Pathol Lab Med; 2024 Jun; 148(6):705-714. PubMed ID: 37948107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammaglobin expression in gynecologic adenocarcinomas.
    Hagemann IS; Pfeifer JD; Cao D
    Hum Pathol; 2013 Apr; 44(4):628-35. PubMed ID: 23084633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of TRPS1 immunohistochemistry in confirming breast carcinoma: Emphasis on staining in triple-negative breast cancers and gynecologic tumors.
    Rammal R; Goel K; Elishaev E; Soong TR; Jones MW; Zhao C; Clark BZ; Carter GJ; Yu J; Fine JL; Villatoro TM; Skvarca L; Harinath L; Bhargava R
    Am J Clin Pathol; 2023 Oct; 160(4):425-434. PubMed ID: 37352847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRPS1 function beyond breast: A retrospective immunohistochemical study on non-breast cytology specimens.
    Ali A; Geetha S; Wu D; Chau K; Karam P; Khutti S; Fayyaz SS; Das K; Gimenez C; Rosca OC
    Diagn Cytopathol; 2024 Sep; 52(9):499-504. PubMed ID: 38794964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations.
    Yemelyanova A; Gown AM; Wu LS; Holmes BJ; Ronnett BM; Vang R
    Int J Gynecol Pathol; 2014 Sep; 33(5):492-9. PubMed ID: 25083965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16 expression in the female genital tract and its value in diagnosis.
    O'Neill CJ; McCluggage WG
    Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas.
    Siami K; McCluggage WG; Ordonez NG; Euscher ED; Malpica A; Sneige N; Silva EG; Deavers MT
    Am J Surg Pathol; 2007 Nov; 31(11):1759-63. PubMed ID: 18059234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX17 is a highly sensitive and specific marker for metastatic ovarian and endometrial carcinomas in cytology cell block specimens.
    Satturwar S; Shaker N; Sinclair W; Shen R; Parwani AV; Ding Q; Li Z
    Cancer Cytopathol; 2023 Jul; 131(7):465-470. PubMed ID: 37195085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis.
    Reid-Nicholson M; Iyengar P; Hummer AJ; Linkov I; Asher M; Soslow RA
    Mod Pathol; 2006 Aug; 19(8):1091-100. PubMed ID: 16648864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
    Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
    Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries.
    Jiang L; Malpica A; Deavers MT; Guo M; Villa LL; Nuovo G; Merino MJ; Silva EG
    Int J Gynecol Pathol; 2010 Mar; 29(2):146-56. PubMed ID: 20173500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichorhinophalangeal Syndrome Type 1 Is a Highly Sensitive and Specific Marker for Diagnosing Triple-Negative Breast Carcinomas on Cytologic Samples.
    Lynn TJ; Shi J; Liu H; Monaco SE; Prichard JW; Lin F
    Arch Pathol Lab Med; 2024 Jan; 148(1):e1-e8. PubMed ID: 37406296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic utility of trichorhinophalangeal syndrome type 1 immunohistochemistry for metastatic breast carcinoma in effusion cytology specimens.
    Chen CJ; Hang JF; Chen YA; Lin SJ; Chiu HM; Hsu CY; Lai CR; Yang CS
    Cancer Cytopathol; 2023 Apr; 131(4):226-233. PubMed ID: 36399408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
    Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
    Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma.
    Chiesa-Vottero AG; Malpica A; Deavers MT; Broaddus R; Nuovo GJ; Silva EG
    Int J Gynecol Pathol; 2007 Jul; 26(3):328-33. PubMed ID: 17581420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.